Next event

  • 05 April 2022
    Publication Fiscal Year Results 2021
  • 04 May 2022
    Annual General Meeting
  • 23 August 2022
    Publication Half Year Results 2022

  • Why invest in SKAN?

    • Market Leader

      Undisputed market leader globally for high-end aseptic process solutions catering the global biopharma industry

    • Technology and innovation

      Technology and innovation leadership with first-to-market solutions and reference point for aseptic manufacturing guidelines

    • Rapidly growing niche market

      Strategically positioned in a highly dynamic and rapidly growing niche market driven by strong underlying end market growth

    • Entry barriers

      Significant barriers to entry due to regulatory requirements and mission criticality of aseptic processes

    • Blue-chip customer base

      Trusted, long-term partner to a large, blue-chip customer base, including all major biopharma companies

    • Excellent financial profile

      Excellent financial profile with demonstrated profitable above-market growth and long-term revenue visibility